electroCore Announces New Patent for Stroke and TIA Treatment
13 déc. 2021 08h55 HE
|
electroCore, Inc.
ROCKAWAY, NJ, Dec. 13, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that the United States Patent...
Highmark Interactive Inc Builds Momentum as the Optimal Choice for NCAA Schools by Announcing Competitive Proposal Win With Ball State University and Addition of the State University of New York at Albany
07 déc. 2021 09h15 HE
|
Highmark Interactive
Highmark continues to disrupt high-performance sport by adding new NCAA Division 1 universities such as the Ball State Cardinals and University at Albany Great Danes to Highmark’s EQ platform. This is...
electroCore to Participate at Canaccord Genuity MedTech & Diagnostics Forum
11 nov. 2021 08h00 HE
|
electroCore, Inc.
ROCKAWAY, NJ, Nov. 11, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will be...
HeadCheck Health Announces the Appointment of New Board Member Specialized in Insurance
08 nov. 2021 07h00 HE
|
HeadCheck Health, Inc.
VANCOUVER, British Columbia, Nov. 08, 2021 (GLOBE NEWSWIRE) -- HeadCheck Health, Inc. ('HeadCheck'), a leading tech-enabled provider of concussion protocol management for sports organizations,...
electroCore to Announce Third Quarter 2021 Financial Results on Thursday, November 4th
21 oct. 2021 08h00 HE
|
electroCore, Inc.
ROCKAWAY, NJ, Oct. 21, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the third...
electroCore Announces Publication Reviewing the Prescribing of gammaCore for the Treatment of Cluster Headache in England
20 oct. 2021 08h00 HE
|
electroCore, Inc.
ROCKAWAY, NJ, Oct. 20, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer-reviewed paper entitled...
Odyssey Group International Files Patent On Novel Breath-Propelled Nasal Delivery Device
19 oct. 2021 10h03 HE
|
Odyssey Group International
IRVINE, CA, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical technology company focused on developing unique, life-saving...
electroCore Announces Regulatory Approval in Canada to Treat Adolescent Migraine
14 oct. 2021 08h00 HE
|
electroCore, Inc.
ROCKAWAY, NJ, Oct. 14, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that the company received an amended Medical...
electroCore Provides Business Update and Select Third Quarter 2021 Financial Guidance
12 oct. 2021 08h00 HE
|
electroCore, Inc.
Third quarter 2021 revenue expected to be approximately $1.5 millionNet cash used to fund operations in the third quarter 2021 of approximately $3.5 million ROCKAWAY, NJ, Oct. 12, 2021 (GLOBE...
electroCore Announces Acceptance of Motion to Dismiss in the Federal Court Securities Class Action Suit
07 oct. 2021 08h00 HE
|
electroCore, Inc.
ROCKAWAY, NJ, Oct. 07, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced the granting of the company’s motion to dismiss the...